BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Uwe Rohrhoff New Chief Executive Officer of Gerresheimer


6/21/2010 6:54:51 AM

DUSSELDORF, Germany, June 21 /CNW/ - Uwe Rohrhoff becomes the new Chief Executive Officer of Gerresheimer AG on June 22, 2010. Uwe Rohrhoff, who has been a member of the Management Board since 2003, was appointed to his new position by the Supervisory Board in March. Uwe Rohrhoff (48) succeeds Dr. Axel Herberg, who headed the business for ten years as CEO and is changing to the Supervisory Board on September 1, 2010.

"We are delighted to have found in Uwe Rohrhoff the ideal CEO for Gerresheimer AG," says Supervisory Board Chairman Gerhard Schulze: "Mr. Rohrhoff stands for continuity and experience and enjoys the trust of customers and employees equally."

Uwe Rohrhoff, a business graduate, works for Gerresheimer for 20 years and was recently responsible for the Moulded Glass Division and the Life Science Research Division. In addition, he has played a decisive role in the expansion of Gerresheimer's US and Chinese business. Uwe Rohrhoff comments: "We will continue in the future to focus on the successful business in the field of pharma and healthcare. At the same time we want to push ahead with internationalization. We are very well positioned and solidly financed to achieve further profitable growth in the future."

As CEO, Uwe Rohrhoff will continue to manage the Moulded Glass Division directly. On the Management Board, Dr. Max Raster takes over responsibility for the Life Science Research Division in addition to the Tubular Glass Division.

Uwe Rohrhoff joined Gerresheimer in 1991 and initially worked in controlling. He became CEO of the US subsidiary Gerresheimer Glass Inc. in 2001 and has many years' experience of international business management.

Dr. Axel Herberg is leaving Gerresheimer under his own volition after his successful work as CEO. Dr. Herberg served the company for twenty years, fifteen of them as a member of the Management Board and ten as CEO. The Supervisory Board thanks him for his outstanding achievements and successful collaboration over the past years. It welcomes Dr. Axel Herberg as a new member of the Supervisory Board, to which he was elected by the Annual General Meeting on April 29, 2010 by a large majority of votes.

About Gerresheimer

Gerresheimer is an internationally leading manufacturer of high-quality specialty products made of glass and plastic for the global pharma & healthcare industry. Our wide product spectrum ranges from pharmaceutical vials to complex drug delivery systems, such as syringe systems, insulin pens and inhalers, for safe dosage and application. Together with our partners we develop solutions which set standards and have role-model status throughout their respective business sectors.

Our Group of companies achieves in Europe, North and South America and Asia sales of about EUR1 billion and employs around 9,400 people. Through top-class technologies, convincing innovations and targeted investments we are systematically expanding our strong market position.

P.S.: If required, we can send you high-resolution data. Reprint free of charge. Please send specimen copy to Gerresheimer. (c) Gerresheimer AG

For further information

Press Contact Investor Relations Contact: Jens Kurten, Director, Corporate Communication & Marketing, Telephone: +49-211-6181-250, Telefax: +49-211-6181-241, E-Mail j.kuerten@gerresheimer.com Anke Linnartz, Director, Investor Relations, Telephone: +49-211-6181-314, Telefax: +49-211-6181-121, E-Mail a.linnartz@gerresheimer.com

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES